Initial low‐dose oral levothyroxine in a child with Down syndrome, myxedema, and cardiogenic shock

Autor:	Cathrin Hällström, Annika Janson, Amira Elimam, Ricard Nergårdh, Mikael Finder, Magnus Iversen
Rok vydání:	2019
Předmět:	Pediatrics medicine.medical_specialty Down syndrome levothyroxine Levothyroxine lcsh:Medicine Case Report Case Reports 030204 cardiovascular system & hematology Body weight myxedema 03 medical and health sciences 0302 clinical medicine Oral administration Intensive care medicine thyroxine lcsh:R5-920 business.industry Cardiogenic shock cardiogenic shock lcsh:R Low dose General Medicine medicine.disease 030220 oncology & carcinogenesis hypothyroidism Myxedema lcsh:Medicine (General) business medicine.drug
Zdroj:	Clinical Case Reports, Vol 7, Iss 7, Pp 1291-1296 (2019) Clinical Case Reports
ISSN:	2050-0904
DOI:	10.1002/ccr3.2169
Popis:	Myxedema is extremely rare in children, and guidelines are lacking. We treated a 12‐year‐old girl with myxedema and cardiogenic shock with initial low dose (0.3‐2.5 μg/kg body weight/day) of oral levothyroxine and intensive care. Oral administration may safely revert children's myxedema in a dosage resembling that for hypothyroidism.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e0b5c3730b453d4c8bf2c8fd1a233ea https://doi.org/10.1002/ccr3.2169 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.